207 related articles for article (PubMed ID: 14601046)
41. Inhibition of DNA adduct formation of PhIP in female F344 rats by dietary conjugated linoleic acid.
Josyula S; He YH; Ruch RJ; Schut HA
Nutr Cancer; 1998; 32(3):132-8. PubMed ID: 10050262
[TBL] [Abstract][Full Text] [Related]
42. Induction of biotransformation enzymes by the carcinogenic air-pollutant 3-nitrobenzanthrone in liver, kidney and lung, after intra-tracheal instillation in rats.
Mizerovská J; Dračínská H; Frei E; Schmeiser HH; Arlt VM; Stiborová M
Mutat Res; 2011 Feb; 720(1-2):34-41. PubMed ID: 21167309
[TBL] [Abstract][Full Text] [Related]
43. The environmental pollutant and carcinogen 3-nitrobenzanthrone induces cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase in rat lung and kidney, thereby enhancing its own genotoxicity.
Stiborová M; Dracínská H; Mizerovská J; Frei E; Schmeiser HH; Hudecek J; Hodek P; Phillips DH; Arlt VM
Toxicology; 2008 May; 247(1):11-22. PubMed ID: 18329153
[TBL] [Abstract][Full Text] [Related]
44. Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency.
Stiborová M; Rupertová M; Frei E
Biochim Biophys Acta; 2011 Jan; 1814(1):175-85. PubMed ID: 20576524
[TBL] [Abstract][Full Text] [Related]
45. Examination of microsomal cytochrome P450-catalyzed in vitro activation of o-phenylphenol to DNA binding metabolite(s) by 32P-postlabeling technique.
Pathak DN; Roy D
Carcinogenesis; 1992 Sep; 13(9):1593-7. PubMed ID: 1394845
[TBL] [Abstract][Full Text] [Related]
46. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
47. In vitro DNA and dGMP adducts formation caused by ochratoxin A.
Obrecht-Pflumio S; Dirheimer G
Chem Biol Interact; 2000 Jun; 127(1):29-44. PubMed ID: 10903417
[TBL] [Abstract][Full Text] [Related]
48. Relationship between content and activity of cytochrome P450 and induction of heterocyclic amine DNA adducts in human liver samples in vivo and in vitro.
Baranczewski P; Möller L
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1071-8. PubMed ID: 15184267
[TBL] [Abstract][Full Text] [Related]
49. Effect of phytochemical intervention on dibenzo[a,l]pyrene-induced DNA adduct formation.
Russell GK; Gupta RC; Vadhanam MV
Mutat Res; 2015 Apr; 774():25-32. PubMed ID: 25794985
[TBL] [Abstract][Full Text] [Related]
50. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
[TBL] [Abstract][Full Text] [Related]
51. 3-Methylcholanthrene elicits DNA adduct formation in the CYP1A1 promoter region and attenuates reporter gene expression in rat H4IIE cells.
Moorthy B; Muthiah K; Fazili IS; Kondraganti SR; Wang L; Couroucli XI; Jiang W
Biochem Biophys Res Commun; 2007 Mar; 354(4):1071-7. PubMed ID: 17276403
[TBL] [Abstract][Full Text] [Related]
52. Cytochrome b5 increases cytochrome P450 3A4-mediated activation of anticancer drug ellipticine to 13-hydroxyellipticine whose covalent binding to DNA is elevated by sulfotransferases and N,O-acetyltransferases.
Stiborová M; Indra R; Moserová M; Cerná V; Rupertová M; Martínek V; Eckschlager T; Kizek R; Frei E
Chem Res Toxicol; 2012 May; 25(5):1075-85. PubMed ID: 22390216
[TBL] [Abstract][Full Text] [Related]
53. Isolation and partial characterization of the adduct formed by 13-hydroxyellipticine with deoxyguanosine in DNA.
Moserova M; Kotrbova V; Rupertova M; Naiman K; Hudecek J; Hodek P; Frei E; Stiborova M
Neuro Endocrinol Lett; 2008 Oct; 29(5):728-32. PubMed ID: 18987592
[TBL] [Abstract][Full Text] [Related]
54. Microsome-mediated bioactivation of dibenzo[a,l]pyrene and identification of DNA adducts by 32P-postlabeling.
Arif JM; Gupta RC
Carcinogenesis; 1997 Oct; 18(10):1999-2007. PubMed ID: 9364012
[TBL] [Abstract][Full Text] [Related]
55. 32P-postlabeling analysis of DNA adducts formed by leukotriene A4 (LTA4).
Funk D; Sorg BL; Lindner SC; Schmeiser HH
Environ Mol Mutagen; 2010 May; 51(4):338-43. PubMed ID: 20120015
[TBL] [Abstract][Full Text] [Related]
56. Modulation of CYP1A1-mediated oxidation of carcinogenic azo dye Sudan I and its binding to DNA by cytochrome b5.
Stiborová M; Martínek V; Schmeiser HH; Frei E
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():35-9. PubMed ID: 17159775
[TBL] [Abstract][Full Text] [Related]
57. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
Wohlin P; Zeisig M; Gustafsson JA; Möller L
Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
[TBL] [Abstract][Full Text] [Related]
58. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1.
Ross MK; Pegram RA
Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683
[TBL] [Abstract][Full Text] [Related]
59. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
Booth ED; Kilgour JD; Robinson SA; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):195-211. PubMed ID: 15013821
[TBL] [Abstract][Full Text] [Related]
60. DNA adducts of the ubiquitous environmental contaminant cyclopenta[cd]pyrene.
Beach AC; Gupta RC
Carcinogenesis; 1994 May; 15(5):1065-72. PubMed ID: 8200070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
